Common allergy pill tested to shield young Diabetics' hearts and kidneys
NCT ID NCT07409714
Summary
This early-stage study is testing whether montelukast, a medication commonly used for asthma and allergies, can help protect the kidneys and blood vessels in teens and young adults with type 2 diabetes. Researchers believe diabetes causes inflammation that damages these organs, and this drug may block that process. The study will measure changes in kidney and blood vessel function in 50 participants over 6 months to see if the treatment is safe and shows promise for future care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.